PhysiologybioRxivPreprint
Pharmacological inhibition of HDAC6 downregulates TGF-β via Smad2/3 acetylation and improves dystrophin-deficient muscles.
A. Osseni, A. Ravel-Chapuis, I. Scionti…·L. Schaeffer
This study shows that inhibiting HDAC6 with tubastatin A improves dystrophin-deficient muscle by reducing fibrosis and restoring microtubules and NMJ through Smad2/3 acetylation and TGF-β signaling inhibition.
DOI 10.1101/2022.01.21.477182